Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Argus Upgrades Teva Pharma (TEVA) to Buy
-
Notable Analyst Rating Changes 08/05: (RVBD) (WFM) (BRCM) Upgraded; (CB) (QCOM) (KRFT) Downgraded
-
Notable Analyst Rating Changes 02/25: (ELN) (CMI) (APPY) Upgraded; (AFFY) (OC) (TEVA) Downgraded
-
Argus Downgrades Teva Pharma (TEVA) to Hold
-
Notable Analyst Rating Changes 08/02: (SOHU) (IPG) (LVS) Upgraded; (WMT) (TEVA) (SLE) Downgraded
-
Argus Starts Teva Pharma (TEVA) at Buy
-
David Moenning's Daily State of the Markets: 3/13